First COVID-19 ICU patients ventilated with Evone, a ventilator co-developed by Comate and Unitron, show remarkably rapid improvement

Two years ago, Ventinova Medical, Unitron and Comate Engineering & Design co-developed Evone, a ventilator with full respiratory control and higher efficient ventilation with lung protective potential. The innovative ventilator is currently undergoing a fast scale-up and is being used in the battle against COVID-19.

A number of COVID-19 patients with severe ARDS have received, or are still receiving ventilation with Evone. The first results show a clear increase on the Horowitz index – an important measure for respiratory status of a patient. Already in the 24-30 hours of FCV ventilation, an improvement ranging from 60% to 150% was observed. Although these results are preliminary and require further validation, they are perfectly in line with already described effects of FCV in ARDS.

Wouter Foulon, Founder of Comate: β€œIt’s very important to us that we are doing everything we can to play our part in the fight against COVID-19. Working together and sharing expertise is crucial during these challenging times.”

Can we assist you in any way? Don’t hesitate to reach out.

Contact us and we’ll do everything to support your initiative.